Movement Alert|Nutanix Inc. Pre-Market Rise 6.29%, Q4 Revenue Beats Expectations with Optimistic FY2027 Guidance

Market Focus
Aug 27

On August 27, Nutanix Inc. rose 6.29% in pre-market trading, trading at approximately $69.96 per share, with turnover of $38,200. The rally was driven by the company's fiscal Q4 results and forward guidance released after market close.

Nutanix reported fiscal Q4 revenue of $757.1 million, significantly beating the analyst consensus estimate of $738.3 million, representing a 15.9% increase from $653.3 million a year earlier. Adjusted gross margin reached 87.7%. However, adjusted EPS of $0.13 missed the $0.49 estimate, though the market responded positively, prioritizing revenue momentum. For fiscal Q1 2027, the company guided revenue of $755 million to $765 million versus the $756 million consensus, while full-year FY2027 guidance of $3.18 billion to $3.23 billion topped the $3.20 billion analyst estimate.

Notably, Nutanix simultaneously launched its Enterprise AI 2.8 platform upgrade, strengthening its positioning in enterprise Agentic AI. UBS had previously raised its price target to $80 from $62, citing a 40%-50% pipeline increase driven by accelerating VMware migrations and stronger partner trends.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10